How much funding has GLC Biotechnology, Inc. raised?

GLC Biotechnology, Inc. has raised $7.8M in total funding, most recently a Grant round.

Who are GLC Biotechnology, Inc.'s investors?

GLC Biotechnology, Inc.'s investors include National Institutes of Health.

When was GLC Biotechnology, Inc. founded?

GLC Biotechnology, Inc. was founded in 2016.

Where is GLC Biotechnology, Inc. headquartered?

GLC Biotechnology, Inc. is headquartered in Hudson, Ohio, United States.

What industry is GLC Biotechnology, Inc. in?

GLC Biotechnology, Inc. operates in Biotech, Healthcare.

How many employees does GLC Biotechnology, Inc. have?

GLC Biotechnology, Inc. has 1-10 employees.

GLC Biotechnology, Inc.

Early Colon Cancer Screening

Hudson, United States · Founded 2016 · $7.8M raised

Biotech

Healthcare

Headquarters: Hudson, Ohio
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: glcbiotechnology.com
Total Funding: $7.8M
Last Round: $6.6M GrantJan 2023
Rounds: 2

About

GLC Biotechnology develops next-generation stool DNA diagnostics using proprietary patented technology aimed at early colon cancer detection. Its flagship test targets pre-cancerous polyp detection at an 82% rate, offering a non-invasive alternative to colonoscopy for mass-market colorectal cancer screening.

Summary

GLC Biotechnology, Inc. is a Biotech company based in Hudson, United States, founded in 2016. It has raised $7.8M in total across 2 rounds, most recently a $6.6M Grant round in Jan 2023. Investors include National Institutes of Health.